The maternal serum triple test (triple screen) measures
the amounts of alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and
estriol (uE3) in your blood. When a test for inhibin A is added, it is called a
quadruple screen. The amounts of these substances help estimate the risk that
your fetus may have certain defects, such as
Down syndrome,
spina bifida, or
anencephaly. This screening is usually done around 15
to 20 weeks of pregnancy.
Each substance tested in a triple or
quadruple screen gives you different information about possible fetal problems.
Together, these results give the best information. Substances tested
are:
- Alpha-fetoprotein (AFP), a substance
naturally produced by the fetus's liver. The level of AFP in the mother's blood
increases steadily during pregnancy.
- An abnormally high AFP level can be a sign
of a
neural tube defect.
- An abnormally low AFP
level can be a sign of Down syndrome.
- Human chorionic gonadotropin (hCG), a
hormone produced by the placenta when a woman becomes pregnant. The level of
hCG steadily increases during the first 8 to 12 weeks of pregnancy, typically
peaks around the 10th week, and then gradually decreases. Abnormally high hCG
can be a sign of Down syndrome.
- Estriol, a form of
estrogen that increases during pregnancy. It is
produced in large amounts by the placenta. Estriol can be detected in the blood
as early as the 9th week of pregnancy and continues to increase until delivery.
Abnormally low estriol can be a sign of Down syndrome.
- Inhibin A, a protein produced by the fetus and placenta.
Abnormally high inhibin A can be a sign of Down syndrome.
When considering your triple or quad screen results,
consider that this test only identifies chances of a possible problem,
not a diagnosis of a problem. But it can help you decide
whether to have diagnostic testing, such as an
amniocentesis, that can tell you for certain whether a
birth defect is present.
How accurate are triple and quadruple screen results?
With the triple or quad screen, there is a chance of getting a
false-positive test result. This means that test
result suggests a possible birth defect when one is actually not present. A
false-positive test result is increasingly likely as you approach age 40. It
can cause undue stress and lead to unnecessary invasive testing (such as
amniocentesis).
Of women whose AFP level is high (suggesting a
neural tube defect), only 1 in 16 to 1 in 33 actually has a fetus with this
defect.1
Of all women who have positive
triple screen results, the vast majority are actually carrying a healthy fetus.
Similarly, negative test results can occasionally be wrong. But the triple
screen does detect most Down syndrome fetuses, particularly in women who are
older than 35. In this age group, at least 80% of fetuses that have Down
syndrome are detected using triple or quadruple screen. The older you are, the
more likely it is to be accurate.1
In one
large study of more than 23,000 women, the quadruple screen detected almost 86%
of all Down syndrome cases. Based on this study, the quadruple test is more
likely to pick up Down syndrome and less likely to be false-positive than the
triple screen.2
Follow-up
Your age and an accurate fetal age are
necessary for interpreting serum screen results. If your test results are
abnormal, your doctor may use a
fetal ultrasound to make sure the fetal age, and
therefore your screen results, are as accurate as possible. An ultrasound can
also be up to 99% accurate in detecting cases of neural tube defects.1
If your serum screen estimates that your risk of
carrying a fetus with Down syndrome is higher than the average risk for your
age, you may choose to have amniocentesis. (Ultrasound can't detect all cases
of Down syndrome.) Amniocentesis provides amniotic fluid that can be tested for
Down syndrome and other chromosome abnormalities.